Doxazosin
Product Images NDC 42254-075

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 42254-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Mesylate Structural Formula (426f6918 7705 4988 A875 823196f43859 01)

Chemical structure of the active ingredient Doxazosin, showing its molecular arrangement with rings, amine, methoxy groups, and a methanesulfonate group.*

FDA Label Image

Study 2 Maximum Flow Rate (426f6918 7705 4988 A875 823196f43859 02)

A bar chart titled 'STUDY 2 Maximum Flow Rate' comparing Placebo, 4 mg, and 8 mg treatments. The y-axis represents symptom scores ranging from -5 to 4, showing negative and positive values for each group. The chart highlights the maximum flow rate changes associated with different doses.*

FDA Label Image

Figure 1 (Study 1)

Two line graphs depicting clinical study results for Doxazosin. The first graph shows mean change in total symptom score from baseline over 14 weeks comparing Doxazosin and placebo groups. The second graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline over 14 weeks for the same groups. Statistically significant differences are indicated on both graphs.*

FDA Label Image

Doxazosin 2mg (426f6918 7705 4988 A875 823196f43859 04)

Doxazosin 2 mg tablets packaging label from Physician Partner, a division of Rebel Distributors Corp. The label states each tablet contains 2 mg Doxazosin Mesylate equivalent to Doxazosin. It is a 30-count package. The white to off-white, capsule-shaped, biconvex compressed tablets have debossed markings. The label includes storage instructions to keep medication at 15°-30°C (59°-86°F) and out of reach of children. The product is Rx only and manufactured by Novopharm Limited, Toronto, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.